Floatz logo

Therapeutic Asset Ratings

462 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
11C-YJH08
Neoplasm
Rahul AggarwalP1C (36)
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAMETHYLENEPHOSPHONIC ACID
Neoplasm
QSAM Therapeutics, Inc.P1C (36)
18f-trx
Neoplasm
Rahul AggarwalP1C (36)
89-zr-dfo-star polyethylene glycol
Neoplasm
Robert Flavell, MD, PhDP1C (36)
Absk121-Nx
Neoplasm
Abbisko Therapeutics Co, LtdP1C (36)
Actm-838
Neoplasm
Actym Therapeutics, Inc.P1C (36)
agx101
Neoplasm
Angiex, Inc.P1C (36)
ak131
Neoplasm
AkesoP1C (36)
al2846
Neoplasm
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1C (36)
Anti-Her2 Car-T Cells
Solid Tumor
China Medical University, ChinaP1C (36)
APG 115
Neoplasm
Ascentage Pharma Group Inc.P1C (36)
Apg-2575
Neoplasm
Ascentage Pharma Group Inc.P1C (36)
ARG
Solid Tumor
ITM Solucin GmbHP1C (36)
asp1012
Neoplasm
Astellas Pharma Global Development, Inc.P1C (36)
asp4396
Neoplasm
Astellas Pharma IncP1C (36)
asp5834
Neoplasm
Astellas Pharma IncP1C (36)
at03-65
Neoplasm
Axcynsis Therapeutics Pte LtdP1C (36)
azd1390
Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (36)
Azeliragon
Neoplasm
NYU Langone HealthP1C (36)
bat6021
Neoplasm
Bio-Thera SolutionsP1C (36)
bb-1705
Neoplasm
Bliss Biopharmaceutical (Hangzhou) Co., LtdP1C (36)
bb-1709
Neoplasm
Bliss Biopharmaceutical (Hangzhou) Co., LtdP1C (36)
Bbi-825
Neoplasm
Boundless Bio, Inc.P1C (36)
Belzutifan
Neoplasm
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)P1C (36)
Benmelstobart
Neoplasm
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1C (36)
Showing 251 to 275 of 462 assets
PreviousPage 11 of 19Next